The semi-liquid drug for Brusonex nasal spray was administered concomitantly with loratadine with no apparent effect on the concentration of loratadine or its main metabolites in the plasma. Mometasone furoate plasma concentrations are undetectable. Coordinated treatment is well tolerated.